Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01Aditya Bardia, Jennifer Friedmann, Seock‐Ah Im et al.|Journal of Clinical Oncology|2024Cited by 163